CervoMed Inc. (CRVO) compared with its closest peers (GRCE, FLNA, MCRB, KPTI, SILO). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $46.28M | -9.9 |
| FILANA THERAPEUTICS, INC. (FLNA) | $46.27M | — |
| Seres Therapeutics, Inc. (MCRB) | $45.43M | 23.2 |
| Karyopharm Therapeutics Inc. (KPTI) | $44.57M | -0.4 |
| Silo Pharma, Inc. (SILO) | $43.59M | — |
| Veru Inc. (VERU) | $42.37M | -2.4 |
| PDS Biotechnology Corporation (PDSB) | $40.23M | — |
| Apollomics, Inc. (APLM) | $37.46M | -0.2 |
| Actinium Pharmaceuticals, Inc. (ATNM) | $34.90M | 3.0 |
| Lite Strategy, Inc. (LITS) | $34.02M | — |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
CRVO overview · CRVO earnings · CRVO financials · CRVO KPIs · CRVO investor relations · CRVO ownership · CRVO filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.